IC
CRL icon

IEQ Capital’s Charles River Laboratories CRL Stock Holding History

IEQ Capital’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-760
Closed -$206K – 1012
2024
Q1 		$206K Buy
+760
New +$181K ﹤0.01% 876
2023
Q2 		– Sell
-1,006
Closed -$203K – 918
2023
Q1 		$203K Buy
+1,006
New +$228K ﹤0.01% 821
2022
Q1 		– Sell
-1,893
Closed -$713K – 817
2021
Q4 		$713K Buy
1,893
+1,131
+148% +$439K 0.02% 371
2021
Q3 		$314K Buy
+762
New +$316K 0.01% 547

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

IEQ Capital's CRL Position: Q2 2024 in Review

IEQ Capital sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 760 shares — an estimated $206K sold.

IEQ Capital first reported a position in CRL in Q3 2021 and held it in 4 quarters. The position peaked at $713K in Q4 2021. 664 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • IEQ Capital reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • IEQ Capital sold 760 Charles River Laboratories shares in Q2 2024, an estimated $206K.
  • IEQ Capital first reported a position in Charles River Laboratories in Q3 2021 and held it in 4 quarters.
  • IEQ Capital's Charles River Laboratories position peaked at $713K in Q4 2021.
  • 664 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on IEQ Capital's 13F filing for Q2 2024, filed 12 Aug 2024.